CompletedNCT03352206
Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Washington University School of Medicine
- Principal Investigator
- Gary Weil, MDWashington University School of Medicine
- Intervention
- 2 drug dose - DA(drug)
- Enrollment
- 20092 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2017 – 2019
Study locations (5)
- Ministry of Health and Medical Services, Suva, Fiji
- Ministere de la Sante Publique et de la Population, Port-au-Prince, Haiti
- Vector Control Research Centre, Puducherry, India
- Universitas Indonesia, Jakarta, Indonesia
- Papua New Guinea Institute for Medical Research, Madang, Papua New Guinea
Collaborators
Case Western Reserve University · Ministere de la Sante Publique et de la Population, Haiti · Indonesia University · Papua New Guinea Institute for Medical Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03352206 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.